QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
per share |
||||
one-half of one redeemable warrant |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page |
||||
1 |
||||
2 |
||||
3 |
||||
4 |
||||
5 |
||||
15 |
||||
20 |
||||
20 |
||||
20 |
||||
20 |
||||
21 |
||||
22 |
||||
22 |
||||
22 |
||||
22 |
||||
23 |
June 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
Prepaid income taxes |
||||||||
|
|
|
|
|||||
Total Current Assets |
||||||||
Marketable securities held in Trust Account |
||||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
||||||||
Current liabilities |
||||||||
Accounts payable and accrued expenses |
$ | $ | ||||||
Advance from related party |
— | |||||||
|
|
|
|
|||||
Total Current Liabilities |
||||||||
Warrant liabilities |
||||||||
Deferred underwriting fee payable |
||||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
|
|
|
|
|||||
Commitments (Note 7) |
||||||||
Class A common stock subject to possible redemption, |
||||||||
|
|
|
|
|||||
Stockholders’ (Deficit) Equity |
||||||||
Preferred stock, $ |
— | |||||||
Class A Common stock, $ |
— | |||||||
Class B Common stock, $ |
||||||||
Additional paid-in capital |
— | |||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Stockholders’ (Deficit) Equity |
( |
) |
||||||
|
|
|
|
|||||
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
$ |
$ |
||||||
|
|
|
|
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Formation and operating costs |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Other income (expense): |
||||||||||||||||
Change in fair value of warrant liability |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Interest earned on marketable securities held in Trust Account |
||||||||||||||||
Unrealized loss on marketable securities held in Trust Account |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other expense, net |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Loss before benefit from (provision for) income taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Benefit from (provision for) income taxes |
— | — | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per share, Class A common stock subject to possible redemption |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted weighted average shares outstanding, Non-redeemable common stock |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per share, Non-redeemable common stock |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||
|
|
|
|
|
|
|
|
Class A Common Stock |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance – January 1, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Common stock subject to possible redemption |
( |
) | ( |
) | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance – March 31, 2021 |
— |
$ |
— |
$ |
$ |
— |
$ |
( |
) |
$ |
( |
) | ||||||||||||||||
Measurement adjustment on redeemable common stock |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) | ( |
) | |||||||||||||||||||
Balance – June 30, 2021 |
— |
$ |
— |
$ |
$ |
$ |
— |
$ |
( |
) |
$ |
( |
) | |||||||||||||||
Class A Common Stock |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance – January 1, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Common stock subject to possible redemption |
( |
) | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||
Net income |
— | — | — | |||||||||||||||||||||||||
Balance – March 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Common stock subject to possible redemption |
— | — | — | |||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance – June 30, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Six Months Ended June 30, |
||||||||
2021 |
2020 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Change in fair value of warrant liability |
||||||||
Interest income earned on marketable securities held in Trust Account |
( |
) | ( |
) | ||||
Unrealized loss on marketable securities held in Trust Account |
||||||||
Deferred income tax provision |
— | |||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | ||||||
Accrued expenses |
( |
) | ||||||
Income taxes payable |
— | |||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Interest withdrawn for tax payments |
||||||||
|
|
|
|
|||||
Net cash provided by investing activities |
||||||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from promissory notes |
— | |||||||
|
|
|
|
|||||
Net cash provided by financing activities |
— |
|||||||
|
|
|
|
|||||
Net Change in Cash |
( |
) |
( |
) | ||||
Cash – Beginning |
||||||||
|
|
|
|
|||||
Cash – Ending |
$ |
|||||||
|
|
|
|
|||||
Non-cash investing and financing activities: |
||||||||
Change in value of Class A common stock subject to possible redemption |
$ |
$ |
( |
) | ||||
|
|
|
|
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Class A Common stock subject to possible redemption |
||||||||||||||||
Numerator: Earnings allocable to Class A common stock subject to possible redemption |
||||||||||||||||
Interest earned on marketable securities held in Trust Account |
$ | $ | $ | $ | ||||||||||||
Unrealized loss on marketable securities held in Trust Account |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Less: interest available to be withdrawn for payment of taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income attributable to Class A common stock subject to possible redemption |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Denominator: Weighted Average Class A Common stock subject to possible redemption |
||||||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income per share, Class A common stock subject to possible redemption |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-Redeemable Common Stock |
||||||||||||||||
Numerator: Net Income (Loss) minus Net Earnings |
||||||||||||||||
Net Income (Loss) |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Net income (loss) allocable to Class A Common stock subject to possible redemption |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-Redeemable Net Income (Loss) |
$ |
( |
) |
$ | ( |
) | $ |
( |
) |
$ |
( |
) | ||||
|
|
|
|
|
|
|
|
|||||||||
Denominator: Weighted Average Non-redeemable common stock |
||||||||||||||||
Basic and diluted weighted average shares outstanding, Non-redeemable common stock(1) |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net (loss) income per share, Non-redeemable common stock |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||
|
|
|
|
|
|
|
|
(1) |
The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than |
• | if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $ |
• | If, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying such warrants. |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
Level 3: | Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. |
Description |
Level |
June 30, 2021 |
December 31, 2020 |
|||||||||
Assets: |
||||||||||||
Marketable securities held in Trust Account |
1 | $ | $ | |||||||||
Liabilities: |
||||||||||||
Warrant Liability – Public Warrants |
1 | |||||||||||
Warrant Liability – Private Placement Warrants |
3 |
Input |
June 30, 2021 |
December 31, 2020 |
||||||
Risk-free interest rate |
% | % | ||||||
Market price of public stock |
$ | $ | ||||||
Dividend Yield |
% | % | ||||||
Implied volatility |
% | % | ||||||
Exercise price |
$ | $ |
For the six month-period ended June 30, 2021 |
Private Placement |
Public |
Warrant Liabilities |
|||||||||
Fair value as of January 1, 2021 |
$ | $ | $ | |||||||||
Change in fair value of warrant liability |
||||||||||||
|
|
|
|
|
|
|||||||
Fair value as of March 31, 2021 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Change in fair value of warrant liability |
||||||||||||
|
|
|
|
|
|
|||||||
Fair value as of June 30, 2021 |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
For the six month-period ended June 30, 2020 |
Private Placement |
Public |
Warrant Liabilities |
|||||||||
Fair value as of January 1, 2020 |
$ | $ | $ | |||||||||
Change in fair value of warrant liability |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Fair value as of March 31, 2020 |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Change in fair value of warrant liability |
,50 | ) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Fair value as of June 30, 2020 |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
• | may significantly dilute the equity interest of investors; |
• | may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock; |
• | could cause a change of control if a substantial number of shares of our Class A common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and |
• | may adversely affect prevailing market prices for our Units, common stock and/or warrants. |
• | default and foreclosure on our assets if our operating revenues after a Business Combination are insufficient to pay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we have made all principal and interest payments when due if the debt security contains covenants that required the maintenance of certain financial ratios or reserves and we breach any such covenant without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain additional financing, if necessary, if the debt security contains covenants restricting our ability to obtain additional financing while such security is outstanding; |
• | our inability to pay dividends on our common stock; |
• |
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes; |
• |
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• |
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; |
• |
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and |
• |
other disadvantages compared to our competitors who have less debt. |
No. |
Description of Exhibit | |
31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS* | Inline XBRL Instance Document- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL Document | |
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document | |
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | The cover page from the Company’s Quarterly report on Form 10-Q for the quarter ended June 30, 2021 has been formatted in Inline XBRL and is included in Exhibits 101. |
* | Filed herewith. |
Osprey Technology Acquisition Corp. | ||||||
Date: August 12, 2021 | By: | /s/ David DiDomenico | ||||
Name: | David DiDomenico | |||||
Title: | Chief Executive Officer and President | |||||
(Principal Executive Officer) | ||||||
Date: August 12, 2021 | By: | /s/ Jeffrey F. Brotman | ||||
Name: | Jeffrey F. Brotman | |||||
Title: | Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |